Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit

Godelieve Alice Goossens, Godelieve Alice Goossens

Abstract

Flushing and locking of intravenous catheters are thought to be essential in the prevention of occlusion. The clinical sign of an occlusion is catheter malfunction and flushing is strongly recommended to ensure a well-functioning catheter. Therefore fluid dynamics, flushing techniques, and sufficient flushing volumes are important matters in adequate flushing in all catheter types. If a catheter is not in use, it is locked. For years, it has been thought that the catheter has to be filled with an anticoagulant to prevent catheter occlusion. Heparin has played a key role in locking venous catheters. However, the high number of risks associated with heparin forces us to look for alternatives. A long time ago, 0.9% sodium chloride was already introduced as locking solution in peripheral cannulas. More recently, a 0.9% sodium chloride lock has also been investigated in other types of catheters. Thrombolytic agents have also been studied as a locking solution because their antithrombotic effect was suggested as superior to heparin. Other catheter lock solutions focus on the anti-infective properties of the locks such as antibiotics and chelating agents. Still, the most effective locking solution will depend on the catheter type and the patient's condition.

Figures

Figure 1
Figure 1
Visible adhesions to the catheter wall.
Figure 2
Figure 2
Build-up of deposits of fibrin and/or infusion fluids and/or drug precipitates.

References

    1. Baskin J. L., Pui C.-H., Reiss U., et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. The Lancet. 2009;374(9684):159–169. doi: 10.1016/S0140-6736(09)60220-8.
    1. Ferroni A., Gaudin F., Guiffant G., et al. Pulsative flushing as a strategy to prevent bacterial colonization of vascular access devices. Medical Devices: Evidence and Research. 2014;7:379–383.
    1. Infusion Nurses Society. Infusion nursing standards of practice. Journal of Infusion Nursing. 2011;34(1, supplement):S1–S110. doi: 10.1097/01.nan.0000393791.46613.51.
    1. Royal College of Nursing IV Therapy Forum. Standards for Infusion Nursing. Royal College of Nursing IV Therapy Forum; 2010.
    1. Schiffer C. A., Mangu P. B., Wade J. C., et al. Central venous catheter care for the patient with cancer: american Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology. 2013;31(10):1357–1370. doi: 10.1200/jco.2012.45.5733.
    1. Goossens G. A. Totally implantable venous access devices: malfunction problems unveiled [Ph.D. dissertation] Leuven, Belgium: KU Leuven; 2011.
    1. Macklin D. What's physics got to do with it? A review of the physical principles of fluid administration. Journal of Vascular Access Devices. 1999;4(2):7–11. doi: 10.2309/108300899775970836.
    1. Tingey K. G. A review of silicone and polyurethane material in IV catheters. Journal of Vascular Access Devices. 2000;5(3):14–16. doi: 10.2309/108300800775564286.
    1. Smith L. H. Implanted ports, computed tomography, power injectors, and catheter rupture. Clinical Journal of Oncology Nursing. 2008;12(5):809–812. doi: 10.1188/08.cjon.809-812.
    1. Vigier J. P., Merckx J., Coquin J. Y., Flaud P., Guiffant G. The use of a hydrodynamic bench for experimental simulation of flushing venous catheters: impact on the technique. Revue Européenne de Technologie Biomédicale. 2005;26(2):147–149. doi: 10.1016/j.rbmret.2005.03.001.
    1. Guiffant G., Durussel J. J., Merckx J., Flaud P., Vigier J. P., Mousset P. Flushing of intravascular access devices (IVADS)—efficacy of pulsed and continuous infusions. Journal of Vascular Access. 2013;13(1):75–78. doi: 10.5301/jva.2011.8487.
    1. Douard M. C., Clement E., Arlet G., et al. Negative catheter-tip culture and diagnosis of catheter-related bacteremia. Nutrition. 1994;10(5):397–404.
    1. Brouns F., Schuermans A., Verhaegen J., De Wever I., Stas M. Infection assessment of totally implanted long-term venous access devices. Journal of Vascular Access. 2006;7(1):24–28.
    1. Dalton M., Pheil N., Lacy J., Dalton J. Does sludge/debris exist in today's vascular access ports? Journal of the Association for Vascular Access. 2014;19(1):23–26. doi: 10.1016/j.java.2013.12.002.
    1. Dalton M., Pheil N., Lacy J., Dalton J. The port clearance test: why it is important to clinicians. Journal of the Association for Vascular Access. 2014;19(1):42–46. doi: 10.1016/j.java.2013.11.002.
    1. Penel N., Neu J.-C., Clisant S., Hoppe H., Devos P., Yazdanpanah Y. Risk factors for early catheter-related infections in cancer patients. Cancer. 2007;110(7):1586–1592. doi: 10.1002/cncr.22942.
    1. Shearer J. Normal saline flush versus dilute heparin flush. National Intravenous Therapy Association. 1987:425–427.
    1. Guiffant G., Flaud P., Dantan P., Dupont C., Merckx J. Incidence of the curvature of a catheter on the variations of the inner volume: application to the peripherally central catheters. ISRN Vascular Medicine. 2012;2012:6. doi: 10.5402/2012/803128.803128
    1. Lapalu J., Losser M.-R., Albert O., et al. Totally implantable port management: impact of positive pressure during needle withdrawal on catheter tip occlusion (an experimental study) Journal of Vascular Access. 2010;11(1):46–51.
    1. Goossens G. A., Jérôme M., Janssens C., et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology. 2013;24(7):1892–1899. doi: 10.1093/annonc/mdt114.mdt114
    1. Polaschegg H.-D., Shah C. Overspill of catheter locking solution: safety and efficacy aspects. American Society for Artificial Internal Organs Journal. 2003;49(6):713–715. doi: 10.1097/01.mat.0000094040.54794.2d.
    1. Polaschegg H.-D. Catheter locking solution spillage: theory and experimental verification. Blood Purification. 2008;26(3):255–260. doi: 10.1159/000123706.
    1. Sona C., Prentice D., Schallom L. National survey of central venous catheter flushing in the intensive care unit. Critical Care Nurse. 2012;32(1):12–19. doi: 10.4037/ccn2012296.
    1. Kefeli U., Dane F., Yumuk P. F., et al. Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. European Journal of Cancer Care. 2009;18(2):191–194. doi: 10.1111/j.1365-2354.2008.00973.x.
    1. Palese A., Baldassar D., Rupil A., et al. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals. European Journal of Oncology Nursing. 2014;18(1):66–71. doi: 10.1016/j.ejon.2013.09.002.
    1. Debb E. N., DiMattia P. E. Standardization of heparin lock maintenance solution. The New England Journal of Medicine. 1976;294(8):p. 448.
    1. Hanson R. L., Grant A. M., Majors K. R. Heparin lock maintenance with ten units of sodium heparin in one milliliter of normal saline solution. Surgery Gynecology and Obstetrics. 1976;142(3):373–376.
    1. Passannante A., Macik B. G. The heparin flush syndrome: a cause of iatrogenic hemorrhage. American Journal of the Medical Sciences. 1988;296(1):71–73. doi: 10.1097/00000441-198807000-00014.
    1. Garcia D. A., Baglin T. P., Weitz J. I., Samama M. M. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2, supplement):e24S–e43S. doi: 10.1378/chest.11-2291.
    1. Horne M. K., III, McCloskey D. J., Calis K., Wesley R., Childs R., Kasten-Sportes C. Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devices. Pharmacotherapy. 2006;26(9 I):1262–1267. doi: 10.1592/phco.26.9.1262.
    1. Toft B. The dangers of heparin flushes. Postgraduate Medical Journal. 2010;86(1012):65–66. doi: 10.1136/qshc.2008.028324.
    1. Kambal A., Najem M., Hussain T. S. Multi-dosage vials, potential for overdose. British Journal of Clinical Pharmacology. 2004;58(6):p. 677. doi: 10.1111/j.1365-2125.2004.02216.x.
    1. Misra S., Koshy T., Sinha P. Identical drug packaging: heparin and midazolam-yet another instance of similar drug packaging. Annals of Cardiac Anaesthesia. 2009;12(1):88–89. doi: 10.4103/0971-9784.45024.
    1. Niccolai C. S., Hicks R. W., Oertel L., Francis J. L. Unfractionated heparin: focus on a high-alert drug. Pharmacotherapy. 2004;24(8, part 2):146S–155S. doi: 10.1592/phco.24.12.146s.36107.
    1. Refaai M. A., Warkentin T. E., Axelson M., Matevosyan K., Sarode R. Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin ‘flushes’. Thrombosis and Haemostasis. 2007;98(5):1139–1140. doi: 10.1160/th07-06-0423.
    1. Garajová I., Nepoti G., Paragona M., Brandi G., Biasco G. Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation. European Journal of Cancer Care. 2013;22(1):125–132. doi: 10.1111/ecc.12008.
    1. Muslimani A. A., Ricaurte B., Daw H. A. Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes. The American Journal of Hematology. 2007;82(7):652–655. doi: 10.1002/ajh.20849.
    1. Lovecchio F. Heparin-induced thrombocytopenia. Clinical Toxicology. 2014;52(6):579–583. doi: 10.3109/15563650.2014.917181.
    1. Shanks R. M. Q., Sargent J. L., Martinez R. M., Graber M. L., O'Toole G. A. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrology Dialysis Transplantation. 2006;21(8):2247–2255. doi: 10.1093/ndt/gfl170.
    1. Liu D., Zhang L.-P., Huang S.-F., et al. Outbreak of Serratia marcescens infection due to contamination of multiple-dose vial of heparin-saline solution used to flush deep venous catheters or peripheral trocars. Journal of Hospital Infection. 2011;77(2):175–176. doi: 10.1016/j.jhin.2010.10.003.
    1. Dias M. B. S., Habert A. B., Borrasca V., et al. Salvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution. Infection Control and Hospital Epidemiology. 2008;29(2):125–130. doi: 10.1086/526440.
    1. Registered Nurses' Association of Ontario. Care and Maintenance to Reduce Vascular Access Complications, Guideline supplement. 2008.
    1. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. OCEBM Levels of Evidence Working Group, Oxford Centre for Evidence-Based Medicine; 2014.
    1. Goode C. J., Titler M., Rakel B., et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nursing Research. 1991;40(6):324–330.
    1. Peterson F. Y., Kirchhoff K. T. Analysis of the research about heparinized versus nonheparinized intravascular lines. Heart & Lung: Journal of Critical Care. 1991;20(6):631–642.
    1. Randolph A. G., Cook D. J., Gonzales C. A., Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. British Medical Journal. 1998;316(7136):969–975. doi: 10.1136/bmj.316.7136.969.
    1. Gyr P., Burroughs T., Smith K., Mahl C., Pontious S., Swerczek L. Double blind comparison of heparin and saline flush solutions in maintenance of peripheral infusion devices. Pediatric Nursing. 1995;21(4):383–389, 366.
    1. LeDuc K. Efficacy of normal saline solution versus heparin solution for maintaining patency of peripheral intravenous catheters in children. Journal of Emergency Nursing. 1997;23(4):306–309. doi: 10.1016/s0099-1767(97)90216-6.
    1. Niesen K. M., Harris D. Y., Parkin L. S., Henn L. T. The effects of heparin versus normal saline for maintenance of peripheral intravenous locks in pregnant women. Journal of Obstetric, Gynecologic, and Neonatal Nursing. 2003;32(4):503–508. doi: 10.1177/0884217503255203.
    1. Mok E., Kwong T. K., Chan M. F. A randomized controlled trial for maintaining peripheral intravenous lock in children. International Journal of Nursing Practice. 2007;13(1):33–45. doi: 10.1111/j.1440-172x.2006.00607.x.
    1. White M. L., Crawley J., Rennie E. A., Lewandowski L. A. Examining the effectiveness of 2 solutions used to flush capped pediatric peripheral intravenous catheters. Journal of Infusion Nursing. 2011;34(4):260–270. doi: 10.1097/nan.0b013e31821da29a.
    1. Bertolino G., Pitassi A., Tinelli C., et al. Intermittent flushing with heparin versus saline for maintenance of peripheral intravenous catheters in a medical department: a pragmatic cluster-randomized controlled study. Worldviews on Evidence-Based Nursing. 2012;9(4):221–226. doi: 10.1111/j.1741-6787.2012.00244.x.
    1. Randolph A. G., Cook D. J., Gonzalez C. A., Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest. 1998;113(1):165–171. doi: 10.1378/chest.113.1.165.
    1. Rabe C., Gramann T., Sons X., et al. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Medicine. 2002;28(8):1172–1176. doi: 10.1007/s00134-002-1379-2.
    1. Schallom M. E., Prentice D., Sona C., Micek S. T., Skrupky L. P. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Critical Care Medicine. 2012;40(6):1820–1826. doi: 10.1097/ccm.0b013e31824e11b4.
    1. Bowers L., Speroni K. G., Jones L., Atherton M. Comparison of occlusion rates by flushing solutions for peripherally inserted central catheters with positive pressure luer-activated devices. Journal of Infusion Nursing. 2008;31(1):22–27. doi: 10.1097/01.nan.0000308542.90615.c2.
    1. Lyons M. G., Phalen A. G. A randomized controlled comparison of flushing protocols in home care patients with peripherally inserted central catheters. Journal of Infusion Nursing. 2014;37(4):270–281. doi: 10.1097/nan.0000000000000050.
    1. Smith S., Dawson S., Hennessey R., Andrew M. Maintenance of the patency of indwelling central venous catheters: is heparin necessary? The American Journal of Pediatric Hematology/Oncology. 1991;13(2):141–143. doi: 10.1097/00043426-199122000-00005.
    1. Hoffer E. K., Borsa J., Santulli P., Bloch R., Fontaine A. B. Prospective randomized comparison of valved versus nonvalved peripherally inserted central vein catheters. American Journal of Roentgenology. 1999;173(5):1393–1398. doi: 10.2214/ajr.173.5.10541127.
    1. Carlo J. T., Lamont J. P., McCarty T. M., Livingston S., Kuhn J. A. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. The American Journal of Surgery. 2004;188(6):722–727. doi: 10.1016/j.amjsurg.2004.08.041.
    1. Cesaro S., Tridello G., Cavaliere M., et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. Journal of Clinical Oncology. 2009;27(12):2059–2065. doi: 10.1200/JCO.2008.19.4860.
    1. Biffi R., de Braud F., Orsi F., et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. 2001;92(5):1204–1212. doi: 10.1002/1097-0142(20010901)92:560;1204::aid-cncr143962;;2-9.
    1. Buehrle D. C. A prospective, randomized comparison of three needleless IV systems used in conjunction with peripherally inserted central catheters. Journal of the Association for Vascular Access. 2004;9(1):35–38. doi: 10.2309/155288504774596752.
    1. Khalidi N., Kovacevich D. S., Papke-O'Donnell L. F., Btaiche I. Impact of the positive pressure valve on vascular access device occlusions and bloodstream infections. Journal of the Association for Vascular Access. 2009;14(2):84–91. doi: 10.2309/java.14-2-6.
    1. Mitchell M. D., Anderson B. J., Williams K., Umscheid C. A. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. Journal of Advanced Nursing. 2009;65(10):2007–2021. doi: 10.1111/j.1365-2648.2009.05103.x.
    1. Dal Molin A., Allara E., Montani D., et al. Flushing the central venous catheter: is heparin necessary? The Journal of Vascular Access. 2014;15(4):241–248. doi: 10.5301/jva.5000225.
    1. Lopez-Briz E., Ruiz G., Cabello V. J. B., Bort-Marti S., Carbonell S. R., Burls A. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. The Cochrane Database of Systematic Reviews. 2014;10 doi: 10.1002/14651858.CD008462.pub2.CD008462
    1. Kethireddy S., Safdar N. Urokinase lock or flush solution for prevention of bloodstream infections associated with central venous catheters for chemotherapy: a meta-analysis of prospective randomized trials. The Journal of Vascular Access. 2008;9(1):51–57.
    1. Solomon B., Moore J., Arthur C., Prince H. M. Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin. European Journal of Cancer. 2001;37(18):2379–2384. doi: 10.1016/s0959-8049(01)00320-3.
    1. Dillon P. W., Jones G. R., Bagnall-Reeb H. A., Buckley J. D., Wiener E. S., Haase G. M. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study. Journal of Clinical Oncology. 2004;22(13):2718–2723. doi: 10.1200/jco.2004.07.019.
    1. Mermel L. A. What is the predominant source of intravascular catheter infections? Clinical Infectious Diseases. 2011;52(2):211–212. doi: 10.1093/cid/ciq108.
    1. Ryder M. Evidence-based practice in the management of vascular access devices for home parenteral nutrition therapy. Journal of Parenteral and Enteral Nutrition. 2006;30(1, supplement):S82–S93. doi: 10.1177/01486071060300s1s82.
    1. Donlan R. M. Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clinical Infectious Diseases. 2011;52(8):1038–1045. doi: 10.1093/cid/cir077.
    1. Messing B., Peitra-Cohen S., Debure A., Beliah M., Bernier J.-J. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. Journal of Parenteral and Enteral Nutrition. 1988;12(2):185–189. doi: 10.1177/0148607188012002185.
    1. Bookstaver P. B., Rokas K. E. E., Norris L. B., Edwards J. M., Sherertz R. J. Stability and compatibility of antimicrobial lock solutions. American Journal of Health-System Pharmacy. 2013;70(24):2185–2198. doi: 10.2146/ajhp120119.
    1. Snaterse M., Rüger W., Scholte op Reimer W. J. M., Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. Journal of Hospital Infection. 2010;75(1):1–11. doi: 10.1016/j.jhin.2009.12.017.
    1. van de Wetering M. D., van Woense J. B., Lawrie T. A. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients. The Cochrane Database of Systematic Reviews. 2013;(11) doi: 10.1002/14651858.CD003295.pub3.CD003295
    1. O'Grady N. P., Alexander M., Burns L. A., et al. Summary of recommendations: guidelines for the Prevention of Intravascular Catheter-related Infections. Clinical Infectious Diseases. 2011;52(9):1087–1099. doi: 10.1093/cid/cir138.
    1. Hoffman L. R., D'Argenio D. A., MacCoss M. J., Zhang Z., Jones R. A., Miller S. I. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 2005;436(7054):1171–1175. doi: 10.1038/nature03912.
    1. Sauer K., Steczko J., Ash S. R. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions. Journal of Antimicrobial Chemotherapy. 2009;63(5):937–945. doi: 10.1093/jac/dkp060.
    1. Raad I., Rosenblatt J., Reitzel R., Jiang Y., Dvorak T., Hachem R. Chelator-based catheter lock solutions in eradicating organisms in biofilm. Antimicrobial Agents and Chemotherapy. 2013;57(1):586–588. doi: 10.1128/AAC.01287-12.
    1. Tan M., Lau J., Guglielmo B. J. Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. Annals of Pharmacotherapy. 2014;48(5):607–615. doi: 10.1177/1060028014524049.
    1. Worth L. J., Slavin M. A., Heath S., Szer J., Grigg A. P. Ethanol versus heparin locks for the prevention of central venous catheter-associated bloodstream infections: a randomized trial in adult haematology patients with Hickman devices. Journal of Hospital Infection. 2014;88(1):48–51. doi: 10.1016/j.jhin.2014.06.007.
    1. Mermel L. A., Alang N. Adverse effects associated with ethanol catheter lock solutions: a systematic review. Journal of Antimicrobial Chemotherapy. 2014;69(10):2611–2619. doi: 10.1093/jac/dku182.
    1. Schilcher G., Schlagenhauf A., Schneditz D., et al. Ethanol causes protein precipitation—new safety issues for catheter locking techniques. PLoS ONE. 2013;8(12) doi: 10.1371/journal.pone.0084869.e84869
    1. Rosenblatt J., Reitzel R., Dvorak T., Jiang Y., Hachem R. Y., Raad I. I. Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms. Antimicrobial Agents and Chemotherapy. 2013;57(8):3555–3560. doi: 10.1128/aac.00229-13.
    1. Olthof E. D., Nijland R., Gülich A. F., Wanten G. J. A. Microbiocidal effects of various taurolidine containing catheter lock solutions. Clinical Nutrition. 2014 doi: 10.1016/j.clnu.2014.04.023.
    1. Traub W. H., Leonhard B., Bauer D. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae . Chemotherapy. 1993;39(5):322–330. doi: 10.1159/000239144.
    1. Liu Y., Zhang A.-Q., Cao L., Xia H.-T., Ma J.-J. Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2013;8(11) doi: 10.1371/journal.pone.0079417.e79417
    1. Dümichen M. J., Seeger K., Lode H. N., et al. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. Journal of Hospital Infection. 2012;80(4):304–309. doi: 10.1016/j.jhin.2012.01.003.
    1. Handrup M. M., Møller J. K., Schrøder H. Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatric Blood & Cancer. 2013;60(8):1292–1298. doi: 10.1002/pbc.24482.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren